Annual Net Income
$333.80 K
+$4.65 M+107.73%
30 April 2024
Summary:
PharmaCyte Biotech annual net profit is currently $333.80 thousand, with the most recent change of +$4.65 million (+107.73%) on 30 April 2024. During the last 3 years, it has risen by +$3.88 million (+109.40%). PMCB annual net income is now at all-time high.PMCB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$23.42 M
+$22.07 M+1639.17%
31 July 2024
Summary:
PharmaCyte Biotech quarterly net profit is currently $23.42 million, with the most recent change of +$22.07 million (+1639.17%) on 31 July 2024. Over the past year, it has increased by +$20.63 million (+739.51%). PMCB quarterly net income is now at all-time high.PMCB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$26.94 M
+$26.60 M+7970.25%
31 July 2024
Summary:
PharmaCyte Biotech TTM net profit is currently $26.94 million, with the most recent change of +$26.60 million (+7970.25%) on 31 July 2024. Over the past year, it has increased by +$28.22 million (+2198.34%). PMCB TTM net income is now at all-time high.PMCB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +107.7% | +739.5% | +2198.3% |
| 3 y3 years | +109.4% | +2490.7% | +823.7% |
| 5 y5 years | +108.2% | +2294.9% | +770.7% |
PMCB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +107.7% | at high | +835.8% | at high | +552.4% |
| 5 y | 5 years | at high | +107.7% | at high | +835.8% | at high | +552.4% |
| alltime | all time | at high | +101.2% | at high | +242.2% | at high | +198.8% |
PharmaCyte Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $23.42 M(+1639.2%) | $26.94 M(+7970.3%) |
| Apr 2024 | $333.80 K(-107.7%) | $1.35 M(-317.4%) | $333.80 K(-129.3%) |
| Jan 2024 | - | -$619.50 K(-122.2%) | -$1.14 M(-11.3%) |
| Oct 2023 | - | $2.79 M(-187.6%) | -$1.28 M(-78.4%) |
| July 2023 | - | -$3.18 M(+2420.4%) | -$5.95 M(+38.0%) |
| Apr 2023 | -$4.32 M(+1.8%) | -$126.30 K(-83.5%) | -$4.32 M(-23.1%) |
| Jan 2023 | - | -$764.10 K(-59.4%) | -$5.61 M(-0.8%) |
| Oct 2022 | - | -$1.88 M(+21.7%) | -$5.66 M(+18.9%) |
| July 2022 | - | -$1.54 M(+8.6%) | -$4.76 M(+12.3%) |
| Apr 2022 | -$4.24 M(+19.4%) | -$1.42 M(+75.4%) | -$4.24 M(+12.3%) |
| Jan 2022 | - | -$811.30 K(-17.2%) | -$3.78 M(+1.5%) |
| Oct 2021 | - | -$979.70 K(-4.5%) | -$3.72 M(+0.8%) |
| July 2021 | - | -$1.03 M(+6.8%) | -$3.69 M(+4.0%) |
| Apr 2021 | -$3.55 M(-7.2%) | -$960.00 K(+26.8%) | -$3.55 M(+6.3%) |
| Jan 2021 | - | -$757.10 K(-20.3%) | -$3.34 M(-3.4%) |
| Oct 2020 | - | -$950.20 K(+7.5%) | -$3.46 M(-3.3%) |
| July 2020 | - | -$883.90 K(+17.8%) | -$3.58 M(-6.5%) |
| Apr 2020 | -$3.83 M(-5.9%) | -$750.40 K(-14.3%) | -$3.83 M(-9.2%) |
| Jan 2020 | - | -$875.30 K(-18.0%) | -$4.22 M(+5.0%) |
| Oct 2019 | - | -$1.07 M(-5.9%) | -$4.02 M(+0.8%) |
| July 2019 | - | -$1.13 M(-0.4%) | -$3.99 M(-2.0%) |
| Apr 2019 | -$4.07 M(-40.4%) | -$1.14 M(+68.4%) | -$4.07 M(-3.7%) |
| Jan 2019 | - | -$676.30 K(-34.8%) | -$4.22 M(-24.3%) |
| Oct 2018 | - | -$1.04 M(-14.7%) | -$5.58 M(-12.2%) |
| July 2018 | - | -$1.22 M(-6.2%) | -$6.36 M(-6.9%) |
| Apr 2018 | -$6.83 M(+53.7%) | -$1.30 M(-36.2%) | -$6.83 M(+2.1%) |
| Jan 2018 | - | -$2.03 M(+11.9%) | -$6.69 M(+12.6%) |
| Oct 2017 | - | -$1.81 M(+7.5%) | -$5.94 M(+16.5%) |
| July 2017 | - | -$1.69 M(+46.2%) | -$5.10 M(+14.8%) |
| Apr 2017 | -$4.44 M(-26.7%) | -$1.16 M(-9.9%) | -$4.44 M(+0.7%) |
| Jan 2017 | - | -$1.28 M(+31.6%) | -$4.41 M(-10.3%) |
| Oct 2016 | - | -$974.60 K(-5.6%) | -$4.92 M(-11.8%) |
| July 2016 | - | -$1.03 M(-8.0%) | -$5.58 M(-8.0%) |
| Apr 2016 | -$6.06 M(-38.9%) | -$1.12 M(-37.4%) | -$6.06 M(-21.9%) |
| Jan 2016 | - | -$1.79 M(+9.5%) | -$7.76 M(+4.5%) |
| Oct 2015 | - | -$1.64 M(+8.0%) | -$7.43 M(-24.6%) |
| July 2015 | - | -$1.51 M(-46.3%) | -$9.86 M(-0.7%) |
| Apr 2015 | -$9.93 M(-63.6%) | -$2.82 M(+93.5%) | -$9.93 M(-57.9%) |
| Jan 2015 | - | -$1.46 M(-64.1%) | -$23.58 M(+4.4%) |
| Oct 2014 | - | -$4.06 M(+156.4%) | -$22.58 M(-6.6%) |
| July 2014 | - | -$1.58 M(-90.4%) | -$24.17 M(-11.3%) |
| Apr 2014 | -$27.25 M | -$16.47 M(+3490.0%) | -$27.25 M(+145.3%) |
| Jan 2014 | - | -$458.80 K(-91.9%) | -$11.11 M(+0.7%) |
| Oct 2013 | - | -$5.66 M(+21.3%) | -$11.03 M(+91.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2013 | - | -$4.67 M(+1326.2%) | -$5.75 M(+260.2%) |
| Apr 2013 | -$1.60 M(-15.9%) | -$327.20 K(-13.2%) | -$1.60 M(-10.0%) |
| Jan 2013 | - | -$376.80 K(-1.6%) | -$1.77 M(+6.3%) |
| Oct 2012 | - | -$382.80 K(-25.0%) | -$1.67 M(-3.2%) |
| July 2012 | - | -$510.50 K(+1.2%) | -$1.72 M(-9.2%) |
| Apr 2012 | -$1.90 M(+35.9%) | -$504.40 K(+85.6%) | -$1.90 M(-23.7%) |
| Jan 2012 | - | -$271.80 K(-37.8%) | -$2.49 M(+6.3%) |
| Oct 2011 | - | -$437.20 K(-36.3%) | -$2.34 M(+20.1%) |
| July 2011 | - | -$686.00 K(-37.3%) | -$1.95 M(+39.5%) |
| Apr 2011 | -$1.40 M(-76.7%) | -$1.09 M(+781.1%) | -$1.40 M(-53.8%) |
| Jan 2011 | - | -$124.10 K(+171.0%) | -$3.02 M(-37.4%) |
| Oct 2010 | - | -$45.80 K(-65.9%) | -$4.83 M(-8.8%) |
| July 2010 | - | -$134.30 K(-95.1%) | -$5.30 M(-11.5%) |
| Apr 2010 | -$5.99 M(-14.9%) | -$2.72 M(+40.6%) | -$5.99 M(-29.4%) |
| Jan 2010 | - | -$1.93 M(+275.9%) | -$8.49 M(+14.3%) |
| Oct 2009 | - | -$514.30 K(-37.7%) | -$7.43 M(+1.3%) |
| July 2009 | - | -$825.90 K(-84.2%) | -$7.33 M(+4.7%) |
| Apr 2009 | -$7.04 M(+85.7%) | -$5.22 M(+499.0%) | -$7.00 M(+145.5%) |
| Jan 2009 | - | -$870.60 K(+108.1%) | -$2.85 M(-2.5%) |
| Oct 2008 | - | -$418.40 K(-16.1%) | -$2.92 M(-13.8%) |
| July 2008 | - | -$498.60 K(-53.2%) | -$3.39 M(-10.5%) |
| Apr 2008 | -$3.79 M(+4.9%) | -$1.07 M(+13.1%) | -$3.79 M(+10.1%) |
| Jan 2008 | - | -$942.30 K(+6.2%) | -$3.44 M(+5.2%) |
| Oct 2007 | - | -$887.40 K(-1.2%) | -$3.27 M(+8.5%) |
| July 2007 | - | -$897.90 K(+25.2%) | -$3.02 M(-16.5%) |
| Apr 2007 | -$3.61 M(-61.5%) | -$717.20 K(-7.1%) | -$3.61 M(-56.2%) |
| Jan 2007 | - | -$772.20 K(+22.6%) | -$8.25 M(+0.5%) |
| Oct 2006 | - | -$630.00 K(-57.9%) | -$8.21 M(-13.5%) |
| July 2006 | - | -$1.49 M(-72.1%) | -$9.49 M(+7.7%) |
| Apr 2006 | -$9.39 M(+119.4%) | -$5.36 M(+635.1%) | -$8.81 M(+54.0%) |
| Jan 2006 | - | -$728.50 K(-61.8%) | -$5.72 M(+5.4%) |
| Oct 2005 | - | -$1.91 M(+133.8%) | -$5.43 M(+14.4%) |
| July 2005 | - | -$816.50 K(-64.0%) | -$4.74 M(+10.9%) |
| Apr 2005 | -$4.28 M(+146.4%) | -$2.27 M(+420.5%) | -$4.28 M(+16.1%) |
| Jan 2005 | - | -$435.20 K(-64.5%) | -$3.68 M(+12.2%) |
| Oct 2004 | - | -$1.23 M(+248.6%) | -$3.28 M(+58.3%) |
| July 2004 | - | -$351.40 K(-79.0%) | -$2.07 M(+19.5%) |
| Apr 2004 | -$1.74 M(+5308.1%) | -$1.67 M(+4558.8%) | -$1.74 M(+2534.3%) |
| Jan 2004 | - | -$35.90 K(+144.2%) | -$65.90 K(+56.2%) |
| Oct 2003 | - | -$14.70 K(+14.0%) | -$42.20 K(+53.5%) |
| July 2003 | - | -$12.90 K(+437.5%) | -$27.50 K(+88.4%) |
| Apr 2003 | -$32.10 K(+7.7%) | -$2400.00(-80.3%) | -$14.60 K(+19.7%) |
| Jan 2003 | - | -$12.20 K | -$12.20 K |
| Apr 2002 | -$29.80 K | - | - |
FAQ
- What is PharmaCyte Biotech annual net profit?
- What is the all time high annual net income for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual net income year-on-year change?
- What is PharmaCyte Biotech quarterly net profit?
- What is the all time high quarterly net income for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly net income year-on-year change?
- What is PharmaCyte Biotech TTM net profit?
- What is the all time high TTM net income for PharmaCyte Biotech?
- What is PharmaCyte Biotech TTM net income year-on-year change?
What is PharmaCyte Biotech annual net profit?
The current annual net income of PMCB is $333.80 K
What is the all time high annual net income for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual net profit is $333.80 K
What is PharmaCyte Biotech annual net income year-on-year change?
Over the past year, PMCB annual net profit has changed by +$4.65 M (+107.73%)
What is PharmaCyte Biotech quarterly net profit?
The current quarterly net income of PMCB is $23.42 M
What is the all time high quarterly net income for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly net profit is $23.42 M
What is PharmaCyte Biotech quarterly net income year-on-year change?
Over the past year, PMCB quarterly net profit has changed by +$20.63 M (+739.51%)
What is PharmaCyte Biotech TTM net profit?
The current TTM net income of PMCB is $26.94 M
What is the all time high TTM net income for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM net profit is $26.94 M
What is PharmaCyte Biotech TTM net income year-on-year change?
Over the past year, PMCB TTM net profit has changed by +$28.22 M (+2198.34%)